benzoxazoles has been researched along with Substance Withdrawal Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Gholami, M; Joghataei, MT; Komaki, A; Kourosh-Arami, M; Lavaie, M; Najafi, Z | 1 |
| Doostmohammadi, J; Hooshmandi, M; Hosseinmardi, N; Janahmadi, M; Khakpai, F; Rohampour, K | 1 |
| Azizi, H; Javan, M; Mirnajafi-Zadeh, J; Mousavi, Y; Semnanian, S | 1 |
| Azizi, H; Davoudi, M; Mirnajafi-Zadeh, J; Semnanian, S | 1 |
| Azizi, H; Hooshmand, B; Javan, M; Semnanian, S | 1 |
| Azizi, H; Mirnajafi-Zadeh, J; Rohampour, K; Semnanian, S | 1 |
| Chen, X; Kirouac, GJ; Li, S; Li, Y; Qi, K; Sui, N; Wang, H | 1 |
| Berrendero, F; Flores, Á; Maldonado, R; Plaza-Zabala, A | 1 |
| Dileone, RJ; Sarhan, M; Sharf, R | 1 |
9 other study(ies) available for benzoxazoles and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Persistent effects of the orexin-1 receptor antagonist SB-334867 on naloxone precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine dependent rats.
Topics: Animals; Behavior, Animal; Benzoxazoles; Disease Models, Animal; Morphine; Morphine Dependence; Naloxone; Naphthyridines; Narcotic Antagonists; Narcotics; Nociceptive Pain; Orexin Receptor Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Urea | 2022 |
Antagonism of orexin type-1 receptors (OX1Rs) attenuates naloxone-precipitated morphine withdrawal syndrome in rat dorsal hippocampus.
Topics: Animals; Benzoxazoles; Hippocampus; Male; Microinjections; Morphine; Naloxone; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Urea | 2017 |
Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats.
Topics: Animals; Benzoxazoles; Locus Coeruleus; Male; Morphine; Morphine Dependence; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Urea | 2014 |
The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
Topics: Animals; Benzoxazoles; Bicuculline; GABA-A Receptor Antagonists; Locus Coeruleus; Male; Microinjections; Morphine; Naloxone; Naphthyridines; Narcotic Antagonists; Orexin Receptor Antagonists; Orexin Receptors; Rats, Wistar; Substance Withdrawal Syndrome; Urea | 2016 |
Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.
Topics: Animals; Benzoxazoles; Disease Models, Animal; Glutamic Acid; Locus Coeruleus; Male; Microinjections; Morphine; Naphthyridines; Orexin Receptor Antagonists; Orexins; Rats, Wistar; Substance Withdrawal Syndrome; Urea | 2017 |
Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
Topics: Animals; Benzoxazoles; Injections, Intraventricular; Locus Coeruleus; Male; Morphine; Morphine Dependence; Naloxone; Naphthyridines; Narcotic Antagonists; Narcotics; Orexin Receptors; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Substance Withdrawal Syndrome; Urea | 2010 |
Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
Topics: Animals; Avoidance Learning; Benzoxazoles; Conditioning, Classical; Disease Models, Animal; Intracellular Signaling Peptides and Proteins; Male; Microinjections; Midline Thalamic Nuclei; Morphine; Naloxone; Naphthyridines; Neuropeptides; Orexin Receptors; Orexins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Substance Withdrawal Syndrome; Urea | 2011 |
Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal.
Topics: Animals; Antigens, Surface; Benzoxazoles; Intracellular Signaling Peptides and Proteins; Isoquinolines; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Microinjections; Molecular Imaging; Naphthyridines; Neuroanatomical Tract-Tracing Techniques; Neuropeptides; Orexin Receptors; Orexins; Paraventricular Hypothalamic Nucleus; Pyridines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Substance Withdrawal Syndrome; Tobacco Use Disorder; Urea | 2012 |
Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.
Topics: Analysis of Variance; Animals; Benzoxazoles; Intracellular Signaling Peptides and Proteins; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Morphine; Naloxone; Naphthyridines; Narcotic Antagonists; Narcotics; Neuropeptides; Nucleus Accumbens; Orexins; Proto-Oncogene Proteins c-fos; Stilbamidines; Substance Withdrawal Syndrome; Urea; Ventral Tegmental Area | 2008 |